Copyright © Inderes 2011 - present. All rights reserved.

BioInvent International

27,8

 

SEK

 

+9,45 %

BINV

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Mindre end 1K følgere
Sammenligne
+9,45%
-1,42%
-27,79%
-36,67%
-29,44%
+71,39%
-23,71%
-14,25%
-97,08%

BioInvent International is a biotechnology company focused on the development of innovative antibody therapies for cancer treatment. The company is researching new treatments that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe, North America and Asia. BioInvent International was founded in 2001 and is headquartered in Lund, Sweden.

Læs mere
Markedsværdi
1,83 mia. SEK
Aktieomsætning
5,58 mio. SEK
Omsætning
44,69 mio.
EBIT %
-1.054,15 %
P/E
-
Udbytteafkast, %
-
Finanskalender
29.4
2025

Generalforsamling '25

29.4
2025

Delårsrapport Q1'25

26.8
2025

Delårsrapport Q2'25

ViserAlle indholdstyper

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.